INTERNATIONAL MYELOMA SOCIETY

23rd International Myeloma Society Annual Meeting

 

23-26 September Glasgow
Close
N. Poster
Poster title
Applicant name
Status
  12-PA A Protocolised Multidisciplinary Workflow for Early Myeloma Directed Therapy in Suspected Light Chain Cast Nephropathy: Outcomes from a Multi-Hospital Network Xinjie Jonathan Tang Received Received
  15-NSP Impact of premedication de-escalation on the incidence of infusion-related reactions with isatuximab Tyler Sandahl Received Received
  41-PA Atrial fibrillation in multiple myeloma: High prevalence, incidence and impact on survival. A population-based study on 8 672 patients diagnosed 2008-2021 from the Swedish Myeloma Registry. Karin Larsson Received Received
  52-PA Biallelic del(1p) and TP53 mutation rates and their overlap with 2+HRCA high-risk in newly diagnosed multiple myeloma: results of an ISO-accredited NHS Genomics Laboratory Hub Sina Beer Received Received
  245-PA Impact of prior anti-BCMA antibody-drug conjugate exposure and high-risk cytogenetics on outcomes with BCMA bispecifics in relapsed/refractory multiple myeloma: a single centre real-world analysis Martin Kaiser Received Received
  291-PA Lysosome-mediated selective removal of eccDNA drives proteasome inhibitor resistance of multiple myeloma by ubiquitination and Piezo1-dependent ESCRT Huihan Wang Received Received
  340-PA POLB 001, an oral p38 MAPK inhibitor for the prevention of cytokine release syndrome Liam Tremble Received Received
  389-PA Real-World Dexamethasone Dose Intensity Patterns in Induction Therapy for Newly Diagnosed Multiple Myeloma in a Mexican Cohort Diego Garzón Recalde Received Received
  403-PA Real-World Outcomes of Anti-CD38-Based Quadruplet Induction Regimens in Newly Diagnosed Multiple Myeloma: A Multinational Latin American Experience. patricio duarte Received Received
  466-PA Survival Outcomes Associated with Daratumumab Use in Multiple Myeloma: A Retrospective Real-World Cohort Analysis Diego Cruz-Contreras Received Received
  508-PA Trends and Disparities in Infection Associated Mortality Among Older Adults with Multiple Myeloma: A CDC WONDER Analysis from 1999 to 2023 Ahad Moulvi Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
00:36
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

23rd International Myeloma Society Annual Meeting

 

23-26 September Glasgow
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 23/09/2030 TO 23/09/2030
Poster
Gallery
Upload
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
                  




PosterSessionOnline
Logo Draft
Logo Cert